EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

Part of paid clinical trials in Morgantown, West Virginia.

Sponsor
West Virginia University
Study ID
NCT07625189
Status
Recruiting
Apply to this trial

Conditions

  • Ablation Techniques
  • Gastrointestinal Lesions
  • Microwave Ablation
  • Pancreatic Lesion
  • RFA

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a single-center, investigator-initiated, prospective observational registry that will collect longitudinal clinical data on adult patients (≥18 years) undergoing endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) or microwave ablation (MWA) for pancreatic and other gastrointestinal/hepatobiliary lesions as part of routine clinical care. The registry will not alter standard-of-care management. Data will be abstracted from the medical record and routine clinical systems. Primary outcomes include change in target lesion size on clinically obtained imaging and overall survival following ablation. Secondary outcomes include changes in tumor biomarkers, adverse events, non-target lesion changes, and patient-reported symptoms.

Key Dates

Start date
Mar 10, 2026
Status verified
May 2026
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Change From Baseline to 1 Month in Target Lesion Size [ Time Frame: Baseline to 1 month ]

Central Contacts

Locations (1)

FacilityCityStateZIP
West Virginia UniversityMorgantownWest Virginia26505

Find similar trials in Morgantown, WV

By research site
West Virginia University· Morgantown, WV

Related Studies